[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid

C84H142N13O40P — CID 162231874

IUPAC[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid
SMILESCC(=O)N[C@@H]1[C@@H](OCCOCCNC(=O)CCCOCC(COCCCC(=O)NCCOCCO[C@H]2O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]2NC(C)=O)(COCCCC(=O)NCCOCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)CC(=O)CCCCCOC(=O)CCC(=O)NCc2cn(CCCCCC(=O)NCCOC3[C@@H](O)[C@@H](COP(C)(=O)O)O[C@H]3n3ccc(=O)[nH]c3=O)nn2)O[C@@H](CO)[C@@H](O)[C@H]1O
InChIInChI=1S/C84H142N13O40P/c1-52(101)90-68-75(116)71(112)57(45-98)135-80(68)130-39-36-122-32-22-85-62(106)16-11-28-125-49-84(50-126-29-12-17-63(107)86-23-33-123-37-40-131-81-69(91-53(2)102)76(117)72(113)58(46-99)136-81,51-127-30-13-18-64(108)87-24-34-124-38-41-132-82-70(92-54(3)103)77(118)73(114)59(47-100)137-82)42-56(104)14-7-6-10-31-128-67(111)20-19-65(109)89-43-55-44-96(95-94-55)26-9-5-8-15-61(105)88-25-35-129-78-74(115)60(48-133-138(4,120)121)134-79(78)97-27-21-66(110)93-83(97)119/h21,27,44,57-60,68-82,98-100,112-118H,5-20,22-26,28-43,45-51H2,1-4H3,(H,85,106)(H,86,107)(H,87,108)(H,88,105)(H,89,109)(H,90,101)(H,91,102)(H,92,103)(H,120,121)(H,93,110,119)/t57-,58-,59+,60+,68-,69-,70+,71+,72+,73-,74-,75-,76-,77+,78?,79+,80-,81-,82+/m0/s1
InChIKeyZVNPHXFOULZZGI-YQWANUFKSA-N
MW2005.09 g/mol
LogP-7.90
Rot. Bonds72

About [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid

[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid (PubChem CID 162231874) has the molecular formula C84H142N13O40P and a molecular weight of 2005.09 g/mol. Its IUPAC name is [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid.

Molecular Properties

Compound Name[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid
PubChem CID162231874
Molecular FormulaC84H142N13O40P
Molecular Weight2005.09 g/mol
Exact Mass2003.92
IUPAC Name[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid
SMILESCC(=O)N[C@@H]1[C@@H](OCCOCCNC(=O)CCCOCC(COCCCC(=O)NCCOCCO[C@H]2O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]2NC(C)=O)(COCCCC(=O)NCCOCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)CC(=O)CCCCCOC(=O)CCC(=O)NCc2cn(CCCCCC(=O)NCCOC3[C@@H](O)[C@@H](COP(C)(=O)O)O[C@H]3n3ccc(=O)[nH]c3=O)nn2)O[C@@H](CO)[C@@H](O)[C@H]1O
InChIInChI=1S/C84H142N13O40P/c1-52(101)90-68-75(116)71(112)57(45-98)135-80(68)130-39-36-122-32-22-85-62(106)16-11-28-125-49-84(50-126-29-12-17-63(107)86-23-33-123-37-40-131-81-69(91-53(2)102)76(117)72(113)58(46-99)136-81,51-127-30-13-18-64(108)87-24-34-124-38-41-132-82-70(92-54(3)103)77(118)73(114)59(47-100)137-82)42-56(104)14-7-6-10-31-128-67(111)20-19-65(109)89-43-55-44-96(95-94-55)26-9-5-8-15-61(105)88-25-35-129-78-74(115)60(48-133-138(4,120)121)134-79(78)97-27-21-66(110)93-83(97)119/h21,27,44,57-60,68-82,98-100,112-118H,5-20,22-26,28-43,45-51H2,1-4H3,(H,85,106)(H,86,107)(H,87,108)(H,88,105)(H,89,109)(H,90,101)(H,91,102)(H,92,103)(H,120,121)(H,93,110,119)/t57-,58-,59+,60+,68-,69-,70+,71+,72+,73-,74-,75-,76-,77+,78?,79+,80-,81-,82+/m0/s1
InChIKeyZVNPHXFOULZZGI-YQWANUFKSA-N
XLogP-7.90
TPSA739.79 Ų
H-Bond Donors20
H-Bond Acceptors43
Rotatable Bonds72
Heavy Atoms138
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002005.09
LogP ≤ 5-7.90
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid?
The IUPAC name of [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid (CID 162231874) is [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid.
What is the SMILES notation for [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid?
The canonical SMILES for [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid is CC(=O)N[C@@H]1[C@@H](OCCOCCNC(=O)CCCOCC(COCCCC(=O)NCCOCCO[C@H]2O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]2NC(C)=O)(COCCCC(=O)NCCOCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)CC(=O)CCCCCOC(=O)CCC(=O)NCc2cn(CCCCCC(=O)NCCOC3[C@@H](O)[C@@H](COP(C)(=O)O)O[C@H]3n3ccc(=O)[nH]c3=O)nn2)O[C@@H](CO)[C@@H](O)[C@H]1O.
What is the InChIKey of [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid?
The InChIKey is ZVNPHXFOULZZGI-YQWANUFKSA-N. The full InChI is InChI=1S/C84H142N13O40P/c1-52(101)90-68-75(116)71(112)57(45-98)135-80(68)130-39-36-122-32-22-85-62(106)16-11-28-125-49-84(50-126-29-12-17-63(107)86-23-33-123-37-40-131-81-69(91-53(2)102)76(117)72(113)58(46-99)136-81,51-127-30-13-18-64(108)87-24-34-124-38-41-132-82-70(92-54(3)103)77(118)73(114)59(47-100)137-82)42-56(104)14-7-6-10-31-128-67(111)20-19-65(109)89-43-55-44-96(95-94-55)26-9-5-8-15-61(105)88-25-35-129-78-74(115)60(48-133-138(4,120)121)134-79(78)97-27-21-66(110)93-83(97)119/h21,27,44,57-60,68-82,98-100,112-118H,5-20,22-26,28-43,45-51H2,1-4H3,(H,85,106)(H,86,107)(H,87,108)(H,88,105)(H,89,109)(H,90,101)(H,91,102)(H,92,103)(H,120,121)(H,93,110,119)/t57-,58-,59+,60+,68-,69-,70+,71+,72+,73-,74-,75-,76-,77+,78?,79+,80-,81-,82+/m0/s1.
What are the key properties of [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid?
[(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid has a molecular weight of 2005.09 g/mol, XLogP of -7.90, 72 rotatable bonds, 20 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,5R)-4-[2-[6-[4-[[[4-[9-[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]-8-[[4-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-8-[[4-[2-[2-[(2S,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethylamino]-4-oxobutoxy]methyl]-6-oxononoxy]-4-oxobutanoyl]amino]methyl]triazol-1-yl]hexanoylamino]ethoxy]-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-methylphosphinic acid is sourced from PubChem (CID 162231874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).